L, M. A.; O, J.; T, L. L. THE INCIDENCE OF DYSLIPIDEMIA AND DIABETES MELLITUS TYPE 2 AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS USING THE FIRST LINE HIGHLY ACTIVE ANTIRETRO-VIRAL THERAPY FOR AT LEAST TWELVE MONTHS IN SOUTHERN PHILIPPINES HIV-AIDS CORE TEAM HUB. J ASEAN Fed Endocr Soc 2019, 34, 17.